Facebook Linkedin Twitter
Inside Precision Medicine U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia

Vertex Pharmaceuticals

CRISPR
News & Features

U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia

0
Senior woman with shoulder pain. Elderly woman is enduring awful ache. Shoulder Pain In An Elderly Person. Senior lady with shoulder pain
News & Features

Vertex Publishes on Its Promising Non-Opioid Pain Reliever 

0
Angled DNA Double Helix
News & Features

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Laura Cowen
0
Using the Epigenome to Guide Development of Gene Edited Therapies
News & Features

Using the Epigenome to Guide Development of Gene Edited Therapies

Helen Albert
0
Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus
News & Features

Bluebird Tightens Sickle Cell Race with BLA for Gene Therapy

0
Vertex Taps Mammoth’s CRISPR Tech in Gene Therapy Deal Worth up to $695M
News & Features

Vertex Taps Mammoth’s CRISPR Tech in Gene Therapy Deal Worth up to $695M

0
Genetic engineering, GMO and Gene manipulation concept. Hand is inserting sequence of DNA. 3D illustration of DNA.
News & Features

Vertex Sweetens Deal with CRISPR Therapeutics by $900M for Blood Disorders Gene Therapy Candidate

0
12Page 2 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine